Use of Novel Tailored Reminders in Rural Primary Care
|ClinicalTrials.gov Identifier: NCT00593073|
Recruitment Status : Completed
First Posted : January 14, 2008
Last Update Posted : September 12, 2008
|Condition or disease||Intervention/treatment|
|Colorectal Cancer||Behavioral: Electronic tailored messaging Behavioral: General Reminder Message|
Screening for colorectal cancer (CRC) remains severely underutilized. Although simple reminders are modestly effective in enhancing preventive care utilization, they are not widely utilized. Even if used widely, the effectiveness of simple reminders is limited, leaving nearly half of patients without screening. One explanation for this is that simple reminders do not address the barriers and resources of the patients and physicians they are designed to prompt. In this study, we will examine the impact on CRC screening of a reminder system that uses the physician as the message source and is tailored to the physician screening preferences and patient-reported characteristics, CRC screening-related barriers, status and CRC susceptibility. This intervention will be compared to a standard CRC health education and screening reminder system.
Touch screen 'Healthy Living' computer kiosks will be placed in 16 Kansas Physicians Engaged in Prevention Research (KPEPR) Network primary care practices. The kiosk program will screen for eligible participants who are at least 50 years of age and not up-to-date with CRC screening and guide eligible participants through a computerized Colorectal Cancer Assessment (CRCA). Kiosk participants will be randomized into either a general CRC health education + screening reminder message (GRM) (N=640) or a patient and physician-tailored CRC + screening reminder message (TRM) (N=640). Immediately upon completion of the CRCA, GRM participants will receive a brief informational flyer with general CRC health education messages and a reminder to get screened routinely for CRC. Participants in the TRM arm will receive an informational flyer that contains messages that are tailored to patient CRC screening barriers, preferences, and attitudes and physician screening preferences (guided by CRC screening options that are available within the local community) in addition to a reminder to get screened for CRC. A 90-day telephone follow-up will assess participant compliance with CRC screening recommendations, participant discussion with their physician regarding CRC screening, and patient satisfaction.
This study will use a novel patient- and physician- tailored messaging approach to promote colorectal cancer screening utilization. This study will help to assess how a practice-based computerized patient activation approach can effectively circumvent the "systems problems" endemic in rural primary care and lay the groundwork for future computer-based primary care intervention studies to help patients make informed health decisions and engage in healthy lifestyle behaviors.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||707 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Use of Novel Tailored Reminders in Rural Primary Care|
|Study Start Date :||July 2005|
|Primary Completion Date :||December 2007|
|Study Completion Date :||December 2007|
Tailored Reminder Message
Behavioral: Electronic tailored messaging
Tailored CRC message based on patient screening barriers, preferences and attitudes and reminder to get screened.
General Reminder Message
Behavioral: General Reminder Message
General CRC health education message and reminder to get screened.
- Baseline assessment while waiting to see primary care physician and 90-day follow-up telephone survey. [ Time Frame: Baseline, 90 Days ]
- Follow-up survey to assess participant discussion of colorectal cancer with their healthcare provider and compliance with CRC screening [ Time Frame: 90 Days ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00593073
|United States, Kansas|
|University of Kansas Medical Center|
|Kansas City, Kansas, United States, 66160|
|Principal Investigator:||Kimberly K. Engelman, PhD||University of Kansas Medical Center|